MSB 2.08% 94.0¢ mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-61

  1. 2,405 Posts.
    lightbulb Created with Sketch. 629
    Good luck with that! Starpharma got its"non approval" letter nearly two years ago and is still in the "review process". I think it will get approval within the next six months, given that its product is currently approved in about 160 countries and selling well with excellent patient acceptance.

    The FDA is influenced greatly by American pharmaceutical interests and politics.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.